Search for

 

1213 results found

Diversity and inclusion in research: beyond the researcher

When we talk about diversity and inclusion in science research, the focus tends to fall on who are the researchers and scientists, but the unintended consequences of poorly designed studies and trials can be  life-threatening . Biomedical, medical and health research needs to...

Annexins 2019 – Bridging the global scientific community

The 10 th International Conference on Annexins, Annexins 2019, was held in Münster, Germany and welcomed approximately 80 delegates from 10 European countries, USA, Brazil, Singapore, Japan, and Australia. It has been 20 years since this biannual conference series started in...

Pandemics, Pharmacology, and Preventable Deaths

The Problem Medicines cause over 1,700 preventable deaths annually in England alone , with drug errors affecting around 20% of patients after hospital discharge , and medicines contributing to up to 7% of hospital deaths . Previous investigations into these avoidable deat...

Emma Baker

Professor Emma Baker, professor of clinical pharmacology, St George’s Hospital, University of London What do you do? and what is a typical week for you? I spend half my time on university work and half my time on NHS work. In the University I am lead for prescribing educati...

Your Society in 2016: On course for success - March 2016

Taking a closer look at the relationship between physical enhancement and pharmacology

The Society's position on medicines and COVID-19

Our current view of the key issues relating to medicines development and use during the COVID-19 pandemic

Pharmacologist in Phrame: Professor Paul White

Professor Paul White, interviewed by Dr Aisah Aubdool.   What is your background and career pathway to date?  I did a BSc, then a PhD in cardiovascular pharmacology at Monash University. After completing a postdoc at the Children’s hospital in Melbourne, I was ecstatic...

Dr Niall Hyland reflects on the past four years and looks to Pharmacology 2020

As our annual meeting Pharmacology 2020 approaches, so does the end of my term as VP Meetings. It seems timely to reflect on the challenges we have faced over the last year as well as the many successes over the past four. Prior to being elected as VP Meetings, I had the ...

Early Career Pharmacologists Advisory Group (ECPAG) update: An introduction to our newest members

It’s really important to the members of the Early Career Pharmacologists Advisory Group (ECPAG) that the group is representative of the early career pharmacologists that we support. As a Trustee, I’m privileged to work with ECPAG’s talented individuals who genuinely care ab...

Researching the history of pharmacology; an antidote to retirement

It is a question that most people approaching retirement ask themselves: ‘what am I going to do after I retire?’, and it was certainly in my mind as I approached my departure from AstraZeneca in 2007. I had spent my whole career as a research pharmacologist, right from the ti...